Various Clinical Presentations and Treatment Modalities of Carcinoma Rectum by Selvakumar, G
THE TAMILNADU Dr. MGR MEDICAL 
UNIVERSITY
CHENNAI, TAMILNADU.
VARIOUS CLINICAL PRESENTATIONS AND TREATMENT
MODALITIES OF CARCINOMA RECTUM  
DISSERTATION SUBMITTED FOR 
M.S. (BRANCH – I) (GENERAL SURGERY)
MARCH – 2007
CERTIFICATE
This is to certify that this dissertation entitled “VARIOUS CLINICAL 
PRESENTATIONS  AND  TREATMENT  MODALITIES  OF 
CARCINOMA RECTUM” submitted  by  Dr.  G.  SELVAKUMAR  to  The 
Tamil Nadu Dr. M.G.R. Medical University, Chennai is in partial fulfillment of 
the requirement for the award of M.S. degree Branch I (General Surgery) and is 
a  bonafide  research  work  carried  out  by  his  under  direct  supervision  and 
guidance. 
Prof. Dr. V. Seetha Raman M.S., Dr. M. Kalyanasundaram M.S., FICS 
Additional Professor, Professor and Head, 
Department of Surgery, Department of Surgery, 
Govt. Rajaji Hospital, Govt. Rajaji Hospital, 
Madurai Medical College, Madurai Medical College,
Madurai. Madurai. 
ACKNOWLEDGEMENT
I  Express  my  profound  thanks  my  unit  Chief 
Prof. Dr. V. Seetha Raman M.S.,,  Addl. Prof.  of Surgery, for his valuable 
guidance and encouragements throughout my study.
I am thankful to Prof. M. Kalyanasundaram, M.S FICS, Professor and 
Head of the  Department  of Surgery  for  all  the helps and valuable guidance 
throughout my study.
I am thankful to our  Dean, Dr. S.M. Sivakumar M.S.,  for permitting 
me to conduct the study.
Last but not the least, I am extremely thankful to all the patients involved 
in this study for their kind co-operation in completing this study.
CONTENTS 
PAGE NO 
1. INTRODUCTION         1
2. AIM         2
3. MATERIALS AND METHODS         3
4. EPIDEMIOLOGY         4
5. ETIOLOGY, STAGING AND PROGNOSIS         6
6. CLINICAL FEATURES       18
7. PREOPERATIVE EVALUATION        21      
8. PRINCIPLES OF SURGICAL OPTION        29
9. RADIATION THERAPY        52
10. CHEMOTHERAPY        56
11. MANAGEMENT OF RECURRENT AND        59
METASTATIC CARCINOMA
12. MASS SCREENING STRATEGY        64
13. RESULTS        65
14. DISCUSSION        70
15. CONCLUSION       75
BIBLIOGRAPHY 
PROFORMA
MASTER CHART
INTRODUCTION
Carcinoma rectum is  a  common affliation  throughout  the  world.  The 
ideal goal of treatment for any patient affiliated with cancer is the eradications 
of  his  malignancy  with  preservation  of  anatomic  and  physiologic  function. 
Unfortunately  the  surgical  treatment  of  rectal  carcinoma  may  require 
concomitant resection of anal sphincter resulting in colostomy.
For many years it was believed that carcinoma was most appropriately 
treated with Abdominoperineal Resection.  But extensive research during the 
last decade has advanced significantly our understanding of the mechanism of 
carcinogenesis.  In  carcinoma rectum there  is  a  well  documental  progression 
form a premalignant to a malignant state, the Polyp – cancer sequence, which 
occurs on the epithelial surface and is readily accessible to the Endoscopist.
This understanding have resulted in increasing use of other methods of 
treatment.  So  if  the  patient  can  be  charted  out  in  the  early  cancer  stage  a 
colostomy can be avoided. In Goligher series 70% of patient treated with rectal 
excision could have been treated with sphincter saving operations with modern 
staplers. In some centers five years survival rate for carcinoma rectum with T1 
No Mo is 100%. So early detection in rectal carcinoma carries a very good 
prognosis.
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AIM
The aim of the study is
1. To find out Age & Sex incidence of carcinoma rectum in our Institution.
2. To  study  the  clinical  presentation  of  cancer  rectum  including  the 
incidence of emergenices.
3. To  study  the  macroscopic  and  histopathological  types  of  rectal 
malignancies in our institution.
4. To find the incidence of rectal malignancies in relation to the distance 
form the anal verge.
5. To  evaluate  the  various  types  of  surgeries  feasible  for  rectal 
malignancies in our institution.
6. To analyse the morbidity and mortality pattern following surgery done of 
carcinoma rectum.
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MATERIALS AND METHODS
This study has been conducted in the department of surgery Govt. Rajaji 
hospital,  Madurai  during  2004-2006.  All  these  patients  were  subjected  to 
detailed  history  and  a  through  clinical  examination  which  included  general 
examination, examination of the abdomen, inspection of the perineum, digital 
rectal  examination,  proctoscopy  and  sigmioidoscopy.  Biopsy  was  taken  for 
Histopathological examination.
All these patients had base line biochemical investigation done which 
included Blood Hb, TC, DC, Urine, Blood Urea, Blood Sugar, Liver function 
test with UltraSonography and Double contrast Barium enema when warranted. 
Preoperatively these patients were counseled with regards to colostomy. During 
the  counseling  session,  a  previous  ostomate  was  included.  Preoperatively 
patient was subjected to bowel preparation with Peglec (Poly ethylene Glycol) 
Preoperative Antibiotics injection cefotaxime 1gm and injection Metranidazole 
500mg 1 hour prior to surgery. Postoperatively, patients were followed up and 
implications the occurred were noted.  Most of these patients  were subjected 
adjuvant chemotherapy in the form of 5FU 500mg first three days, fort nightly 
cycles for 6 months, with Levamisole 150mg on day 1st, 2nd and 15th, 16th day 
per month and the patient was re-evaluated for presence of local recurrence and 
secondaries. All these data were recorded in a Proforma for study purpose.
7
EPIDEMIOLOGY
The  incidence  of  large  bowel  cancer  varies  between  and  within 
countries,  which strongly suggests  an environmental cause.  The incidence is 
almost equal between the sexes, with some difference in risk ration for cancers 
of  different  parts  of  the  large  bowel,  Rectal  cancers  are  twice  as  common 
among men but for the rest of the large bowel the male : female ration is about 
08 :1 with right – sided cancers even more common in women.
The incidence of large bowel cancer is high in the urban ‘Western’ world 
but is rare is Asia, Africa and parts of south America. There are also apparent 
geographical differences in incidence with in countries.
Approximate incidence per 1,00,000 people
Africa 2
Asia 15
South America 15
West Europe 40
USA 35
For example the incidence is higher in Scotland than in England, and 
higher in Northern Italy and the northern United States than in the southern 
parts of the same countries. The mirror changes in incidence of coronary heart 
disease. This north / south divide is not a fundamental association with latitude. 
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The  incidence  of  bowel  cancer  among  the  Finns  and  the  Eskimos  is  low, 
suggesting the differences are more likely to be due to differences in social and 
dietary behaviours, perhaps induced by climatic changes. The incidence is also 
different  in  cultural  groups  within  countries  for  example,  18/100000  white 
South Africans have colorectal cancer which the incidence amongst there black 
compatriots is about 6/100 000. The proportions in New Zealand whites and 
Maoris  are  similarly  3:1.  though the  incidence is  about  twice that  of  South 
Africa. 
The peak incidence for the disease is in the seventh decade, some 5 years 
later  than  the  corresponding  peak  for  colonic  adenomatous  polyps,  which 
suggests  that  prolonged  exposure  to  weak  environmental  carcinogens  is 
necessary to induce tumours and that most, possibly all, pass through the benign 
phase before turning malignant. 
The epidemiology of proximal and distal rectal cancer is not the same 
worldwide. The ration of rectal to colonic cancer varies from 1:3 in white South 
African males to 1:1 in Finns and Maoris.
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AETIOLOGY AND PATHOGENESIS
GENETIC FACTORS :
The epidemiological evidence so far suggests that environment factors 
predominate  in  the  genesis  of  large bowel  cancer  within populations,  but  it 
would be surprising if inherited genetic factors did not play a numerically small 
yet important role in the formation of colorectal cancers.
Colorectal  cancer,  in common with all  tumours,  show qualitative and 
often quantitative changes in the chromosomes when compared to normal cell. 
Many colon cell line show chromosome distortion, with trisomy of some or 
many chromosomes, sometimes to the point aneuploidy. There is evidence to 
suggest  that  tumours with a poor bizarre  chromosomal configuration with a 
greater proportion of aneuploid cells.
Some genes or gene deletions may also provide some protection against 
the  development  of  cancer,  in  much  the  same  way  that  possession  of  the 
recessive sickle – cell or thalassaemia genes protect against malaria to some 
extent. It seems that the cystic fibrosis gene deletion, Delta F508 condon, which 
is carried by about 1 in 27 people, may protect against colorectal cancer and 
some other tumours.
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ADENOMAS AND PAPILLOMAS:
According to Dukes there exists a close relationship between benign and 
malignant epithelial tumours of the intestine. The following observations are in 
favour of above statement.
1. It has been frequently observed that patient with adenoma or papilloma 
of colon and rectum have developed carcinoma.
2. Often there exists  a  small  focus of  carcinoma in a tumors which has 
histological  characteristics  of  adenoma,  and  villous  papillomas  in  its 
greater part.
3. On careful search a surviving position of a benign tumour may be seen at 
the edge of a frank carcinoma.
The risk of malignant transformation depends on the characteristic of the 
adenoma.   Nearly  5%  of  the  tubular  adenoma,  22.5%  of  tubulovillous 
polyps and 40% of villous adenoma contain carcinoma. When adenoma are 
less than 2cm diameter only 1% of tubular polyps contain carcinomas as 
compared with 3.5% papillovillous and 10% villous adenoma. In tumour 
over 2cm in size carcinoma is present in 35% of tubular adenoma and over 
50% of villous tumours. 
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CANCER PROMOTORS AND INHIBITORS:
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PROMOTORS
Genetic Familial adenomatous
Polyposis
Hereditary
Non – polyposis
Colonic Cancer
Peutz – Jegher’s syndrome
Juvenile Polyposis syndrome
Diet Fat
Bacteria Bile acids
Operations Nuclear
Dehydrogenases
Producing Clostridia
Cholecystectomy
Gastric surgery
Ureterosigmoidostomy
Irradiation Ulcerative colitis
Diseases Crohns diseases
Calcium Increase cellular adhesion; decreases 
cellular proliferation
Vitamin D Retards in vitro growth of human cancer 
cells, lowers level of ornithine 
decarboxylase in rates
Vitamin C Difficiency increases colon carcinogenesis 
by alatonin A: administration may suppress 
experimental colon tumours.
Vitamin E Free radical scavengers shown both to 
inhibit and to promote colon tumor growth 
in carcino genesis models.
Daily sulfide (Garlic Compound) Inhibit carcinogen induced nuclear injury.
Allyl methyl trisulfide Increases activity of glutathione 
(garlic compound) S-transferase, which may inactivate 
carcinogensx
INHIBITORS
MICRONUTRIENTS MECHANISM OF ACTION
IRRADIATION :
X – rays are important mutagens. It is therefore hardly surprising that 
intracavitary  irradiation  in  the  treatment  of  carcinoma of  the  cervix  uteri  is 
associated with a small increased incidence of rectal cancer within the field of 
irradiation. These cancers appear some 5 to 15 years later. 
INFLAMMATORY BOWEL DISEASE
Ulcerative colitis, for a long time, have been known to increase the risk 
of colorectal cancer. The risk increases almost exponential with some 10 years 
after the onset of the disease, particularly in patients  who have total  colitis, 
those with a severe first attack, those who develop the disease in childhood, and 
those  patients  whose  disease  follows  a  relapsing  course.  Patients  with  mild 
distal colitis have no greater risk of developing cancer rectum than the normal 
population  while  patients  with  severe  long  standing  disease  have  a  1  in  2 
change of developing cancer after 30 years. Areas of dysplasia may be scattered 
throughout  the  colon,  and  rectum  which  explains  the  greater  likelihood  of 
multiple cancers among those with colitis. The tumour are seldom exophitic but 
usually  flat  and  infiltrating,  which  makes  diagnosis  more  difficult.  The 
prognosis of these colitis cancers was originally thought to be particularly poor 
but more recent date suggests that stage there is no difference in prognosis of 
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these  colitis  cancers  among  those  with  colitis.  The  tumours  are  seldom 
exophitic but usually flat and infiltrating, which makes diagnosis more difficult. 
The  progression  of  theses  colitis  to  cancers  was  originally  thought  to  be 
particularly poor but more recent data suggests that stage, there is no difference 
in prognosis  compared to sporadic cancers.  Crohns colitis  is  also associated 
with an increased risk of cancer in the disease segment as well as in other area 
of the digestive tract. The risk is, however less than that associated with severe 
ulcerative colitis.
IMMUNO SUPPRESSION:
Long – term immunosuppression, either for the prevention of transplant 
rejection  or  as  a  consequence  of  HIV  infection,  predisposes  to  cancer. 
Lymphomas,  which  may  affect  the  colon  and  rectum in  immunosuppressed 
transplant patients. Small cell carcinomas of the colon and rectum which are 
rare in the otherwise healthy population have been reported in AIDS patients. 
However, there appears to be no associated between adenocarcinomas of the 
colon, rectum and immunosupppression. Neoplasms  themselves  induce  some 
degree  of  immune  suppression,  either  directly  through  products  of  the 
malignant cells or indirectly through malnutrition and cachexia. Suppression of 
this immune response is probably mediated by secretion of soluble suppressor 
factors such as the retroviral protein p15E which is also responsible in a number 
of tumours including colorectal cancers.
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PATHOLOGY, STAGING AND PROGNOSIS
 Colorectal  cancers,  in  common  with  most  epithelial  tumours,  are 
polyclonal with clones of cells exhibiting differing degrees of ‘Malignancy’. 
The more undifferentiated or more ‘Malignant’ clones are more likely to spread 
and metastasize. A tumour’s biological behaviour is the main determinant of the 
tumour’s  propensity  to  spread  locally  and  to  metastasize  and,  therefore, 
indicates  the  ultimate  prognosis.  This  is  reflected  to  some  extent  by  the 
Histopathological features of a cancer.  Tumour secondaries,  which are often 
derived from selected clones of a polyclonal primary, are likely to behave in the 
same way as the primary tumour and will generally be more malignant. 
Tumour biology is very much reflected by the stage of the disease. It is 
no surprise that  there  is  a  significant inverse relation between the length of 
history  and the  stage  of  the  disease  at  diagnosis.  Quicker  growing tumours 
usually present with a short history and are advanced at  the time of treatment. 
Although the  clinical  and pathological  stage is  a  ‘snapshot’  in  the  life  of  a 
tumour,  it  provides the most accurate prognostic index; this  may be refined 
further by the Histopathological features. Several staging methods are in use 
throughout the world, and each has its own strengths and weaknesses. The most 
commonly used are the Duke’s classification and derivations of it, or the Union 
international  Cancer  center  (UICC) TNM classification.  The former  has  the 
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advantages  of  great  simplicity  but  considerable  disadvantages  from  lack  of 
precision. It  does not reflect  accurately the depth of tumour penetration, the 
extent of spread outside the bowel,  the number of lymph nodes affected by 
tumour or the presence or absence of metastasis, all of which have an important 
bearing upon prognosis. Derivations such as the Astler – Coller and Australian 
classifications refine the Duke’s staging but do not provide the flexibility of the 
TNM method, which enables useful division into subsets without being unduly 
complex.  It  is  therefore  most  appropriate  that  surgeons  adopt  the  TNM 
classification as a suitable international standard.
Staging gives information about prognosis  in general,  but particularly 
indicates the probability of occult hepatic metastases. Which is the major factor 
affecting survival. Patients with Dukes C tumour are more likely to have occult 
hepatic metastasis. Occult hepatic metastases account for the majority of deaths 
from colorectal cancer while only about 20% of patients die from local spread 
of the disease, which is also reflected, in the clinical stage.
STAGING OF TUMOUR:
1. Dukes classified carcinoma of the rectum into three stages.
Stage A : The growth is limited to the rectal wall 
(15%)  prognosis excellent
Stage B : The growth has extended to the extra rectal 
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tissues  but  no  metastasis  to  the  regional 
lymph modes (35%) prognosis reasonable.
Stage C : There are secondary deposits in the regional 
lymph nodes (50%) prognosis bad.
ASTLER AND COLLER (1954) :
Has made this classification more accurately interims of prognosis
Stage A : Lesion limited to mucosa.
Stage B1 : Lesion penetrating muscularis propia but not 
through it.
Stage B2 : Lesion penetrating muscularis and extending 
into the serosa. Negative lymph nodes.
Stage C1 : Lesion  involves  all  layers  of  bowel  wall 
except 
serosa positive lymph nodes
Stage C2 : Lesion involves all layers of the bowel walls 
including serosa positive lymph nodes.
Stage D : Distant Metastasis
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TNM  CLASSIFICATION
Metastasis
No (Mo)      Yes 
(MI)
       Nodes involved
No Yes (N1-3)
Tumours Depth Number Involved
Submucosa Muscularis Subserosa Serosa outside 
±  other organ Pericolic Vasuclar 
involvement     (Central 
Group)
         T1       T2        T3    T4
1-3 4(or)>4
Any
N1      N2 N3
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MACROSCOPIC APPEARNACE :
Macroscopically cancer rectum may be
1. Proliferative
2. Ulcerative
3. Annular
4. Diffusely infiltrating 
5. Colloid
1. The proliferative type is the most frequently occurring one. It forms a 
fleshy bulky polypoid mass that bulges into the lumen of the bowel. It is 
a malignant adenoma of slow growth and of low order of malignancy 
and arises form the wall of the gut form a wide base. The proliferate 
growths are usually well differentiated adenocarcinoma.
2. Ulcerative  growth  present  as  a  typical  malignant  lesion  with  raised 
irregular everted edges and a sloughing floor. It has tendency to infiltrate 
the bowel wall. 
3. The annular type of growths is seen typically in the upper 1/3 of the 
rectum. Small densely hard slow growing tumour that do not project into 
the  rectum  apparently  but  tends  to  encircle  the  gut  was  and  thus 
obstructing the passage of solid faecal matter.
4. Diffusely infiltrating carcinoma colon & rectum. It  proceeds a diffuse 
thickening of the intestinal wall usually extending at least 5 to 8 mm and 
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for the most part covered with mucosa but there is usually ulceration at 
some point. This form of carcinoma is some times found as an extension 
of one of the other gross type of the growth. It is also not infrequently 
the type of the growth. It is also the infrequently the type of carcinoma 
that develops in ulcerative colitis.
5. Colloid carcinoma usually forms a bulky growth with very suggestive of 
gelatinous  appearance.  There  may  not  be  extensive  ulceration  and 
infiltration.
HISTOPATHOLOGICAL GRADING AND TYPING:
Grading  depending  upon  subjective  interpretation  of  the  degree  of 
differentiation at histological examination. Various grading systems have been 
proposed, but grading into two broad groups, low or average grade tumours 
which are well to moderately differentiated and high grade or undifferentiated 
induces the variation between observers while at the same time providing useful 
prognostic information. Patients with high grade cancers have worse prognosis 
when  compared  with  patients  with  well  differentiated  lesions  after  taking 
account of the tumour stage.
Typing on the other hand reflects the cellular characteristics. Mucinous 
signet  cell  and  small  cell  tumour  are  the  variants  of  the  more  common 
adenocarcinoma and the frankly undifferentiated cancers again typing may give 
some cell  tumour  have  a  prognostic  information.  Signet  cell  and small  cell 
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tumours have a worse prognosis than adenocarcinoma. While mucinous lesions 
tend to recur locally.. Both of these tumours are however more common in the 
anus. Other varieties are carcinoid and Leiomyosarcoma.
Histological features such as vascular, lymphatic or per neural invasion 
are  prognostically  unfavourable.  By  contrast  lymphocytic  infiltration  of  the 
tumour  and  a  histolytic  reaction  in  the  regional  lymph  nodes  are  minor 
favourable prognostic features.
Identification  of  surface  tumour  antigens  such  as  carcinoembryonic 
antigen, oncogene expression and DNA ploidy potential refinement but these 
are not yet in routine use.
PROGNOSIS
Stage remains the most important indicator of prognosis. The prognosis 
of patients with adequately treated Stage IV cancers is little different from that 
of an otherwise healthy population of the same age. 95 to 100% live 5 years of 
more after resection. Patients with cancer spread through the serosa only have a 
40 to 60% chance of living 5 years, although the prognosis is more favourable 
if the tumour is only just through the serosa and is correspondingly worse if 
adjacent  structures  are  invaded.  Lymph  node  metastasis  further  adversely 
affects  prognosis  with  only  about  30%  of  patients  surving  5  years.  Sub 
classification is  useful.  The survival  curve of  patients  with colon and rectal 
cancer treated by resection is curvilinear, reaching a nearly flat plateau. 
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CLINICAL FEATURES
Carcinoma of the rectum is not uncommon early in life and when the 
disease commences in youth in spite of radical treatment, death usually results 
within a year. Usually the early symptoms are so slight that the patient does not 
seek advice for 6 months or more.
COMMON
o Abdominal pain
o Bleeding
o Unexplained anemia
o Change in bowel habits
UNCOMMON
o Acute
   - Obstruction
   -  Perforation
o Abdominal mass
o Metastatic disease
BLEEDING:
Bleeding is the earliest and most constant symptom. There is nothing 
characteristic  about  the  time at  which it  occurs  neither  is  the  colour  or  the 
amount of blood distinctive. Often the bleeding is slight in amount, and occurs 
at   the  end of  defection  or  is  noticed  because  it  has  stained underclothing. 
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Indeed more  often  then  not  the  bleeding in  every  respect  simulated  that  of 
internal  hemorrhoids  and  it  is  lamentable  that,  in  spite  of  the  repeated 
exhortation,  the  patient’s  doctor  sometimes  fails  to  examine  the  rectum but 
prescribe a salve while the growth advances to inoperability.
SENSE OF INCOMPLETE DEFAECTION:
The patient has his bowels open but feels that there are more faeces to be 
passed.  This  is  a  very  important  early  symptoms  and  is  almost  invariably 
present in tumours of the lower half of the rectum. The patient may endeavour 
to empty the  rectum several  times a day (spurious  diarrhea),  often with the 
passage of flatus and a little bloodstained mucus (blood slime).
ALTERATION IN BOWEL HABIT:
Alteration  in  bowel  Habit  is  the  next  most  frequent  symptom.  The 
patients may find it necessary to start taking an aperients, or to supplement his 
usual doses and as a result a tendency towards diarrhea ensues. A Patient who 
has to get up before the accustomed hour in order to defecate and one who 
passes blood and mucus in addition to fasces (early morning bloody diarrhoea) 
is usually found to be suffering from carcinoma of the rectum. Usually it is the 
patient with an annular carcinoma at the pelvirectal junction who suffers with 
increasing  constipation,  and  the  one  with  a  growth  in  the  ampulla’s  of  the 
rectum with early morning diarrhoea.
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PAIN:
Pain  is  a  late  symptom but  pain  of  a  colicky  character  accompanies 
advanced growths of the recto sigmoid and is due to some degree of intestinal 
obstruction.  When  a  deep  carcinomatous  ulcer  of  the  rectum  invades  the 
prostate or bladder, there is  severe pain. Pain in the back, or sciatica, occurs 
when the growth invades the sacral plexus. Weight loss is suggestive of hepatic 
metastases. When the peritoneum has become studded with secondary deposits 
ascites results.
 MANIFESTATIONS OF ADVANCED DISEASE
• Locally  advanced  ---   Dysuria  ,↑frequency  rectal  cancers        -- 
Neuropathic pain syndrome    
    Females               –   RVF
• Metastatic   Liver metastasis    - -  Jaundice       
          Hepatomegaly
Supraclavicular node enlargement
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PRE-OPERATIVE EVALUATION
Preoperative evaluation should include the following
CARCINOEMBRYONIC ANTIGEN:
First  described  by  (Gold  and  Freedman)  in  1965,  carcinoembryonic 
antigen is a foetal protein present in tumours of the gastrointestinal tract and in 
foetal  tissue  but  not  in  adult  intestinal  tissue.  Plasma  concentration  of 
carcinoembryonic antigen maybe elevated in patients with colorectal carcinoma 
but they may also be normal.
In addition, elevated plasma concentrations of carcinoembryonic antigen 
occur  in  patients  with  cholelithiasis,  alcoholic  and  chronic  active  hepatitis, 
diverticulitis,  pancreatitis,  renal  failure  and fibrocystic  breast  disease  and in 
patients  who  smoke.  This  lack  of  specificity  precludes  carcinoembryonic 
antigen  assays  as  a  screening  test.  The  preoperative  concentration  of 
carcinoembryonic antigen has prognositc importance and has been shown to 
correlate with the size and degree of differentiation of carcinomas of the colon 
and rectum. Combined data from several  large series have indicated that  an 
elevated preoperative carcinoembryonic antigen concentration correlated with 
poorer survival patients with carcinoma of the colon and rectum, independent of 
the stage of disease at diagnosis. After curative resection, the Carcinoembryonic 
antigen  concentration  usually  returns  to  normal  within  one  month.  A 
persistently elevated concentration implies residual disease.
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CLINICAL APPLICATIONS FOR MOLECULAR
MARKERS IN COLORECTAL CARCINOMA
SCREENING:
Molecular analysis of endoscopic biopsies.
Identification of high – risk allelotypic change
Use of proliferative markers (ornithine decarboxylase) to indentify 
preneoplastic change.
DIAGNOSIS:
Molecular analysis to identify risk factor for invasion and metastases to select 
aggressive surgery for polyps or aggressive adjuvant therapy for carcinoma.
Intra operative immuno detection to identify occult metastases and guide 
surgery.
POST OPERATIVE FELLOW UP:
Serial scanning with mixed monoclonal products.
TREATMENT:
Pharmacologic manipulation of signal transduction and surface molecules.
Monoclonal derived immunothrapy or chemotherapy.
Active immunotherapy utilizing tumour specific antigens.
BIOCHEMICAL MARKERS
In the last decade, the molecular biologist have revolutionized the 
understanding of the genetic mechanisms of carcinogenesis and our ability to 
manipulate the genome. The immunobiologist have been able to develop the means by 
which onco developmental antigens, unmasked bygenetic events can form detection to 
management of metastatic disease these development will effect change in clinical 
practice (Passaro E)25.
At the screening level, use of molecular analysis may detect in early life those 
individuals who carry genetic defect. Searching for individuals who are hemizygous 
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for tumour suppressor genes may identify a population at high risk. Use of mucosal 
proliferative markers such as polyamine metabolic enzymes such as ornithine 
decarboxylase form normal mucosa may identify individuals who already show 
expansion of the proliferate compartment.
Analysis of tumor tissues by the same molecular techniques may provide 
important prognostic information. The loss of the DCC locus, the appearance of 
surface CEA or increased amounts of plasminogen activators such as urokinase may 
identify the biologically more aggressive tumor This information may incline the 
surgeon to recommend resection for dysplastic polyp or select candidates more 
accurately for adjuvant chemotherapy.
TUMOUR PLOIDY:
The technology exists to analyse DNA from small biopsy specimens of 
tumours using flow cytometry. Ploidy may correlate with the clinical behavior of the 
tumor. Tumours in early Astler – coller stage tended to be non deployed Aneuploidy is 
an independent predictor of recurrent disease. Other investigation have demonstrated 
that the ploidy status is of equal or greater importance as a prognostic indicator than 
the pathologic stage of the lesion. Ploidy may have carcinoma; however its exact role 
will need to be studied as it becomes a prognostic cariable in therapeutic trials.
EVALUATION OF SYNCHRONOUS LESIONS:
The incidence of synchronous carcinoma has been reported to be between 2% 
and 7 and the incidence of synchronous benign polyposis 12% to 62%. Before 
resection total colonic evaluation should be performed to detect the presence of a 
synchronous lesion. Colonoscopy is the preferred method for this evaluation. 
Synchronous polyps may be excised. In a review of 389 patients. It has been found 
that one half of the synchronous carcinomas found by colonoscopy were not detected 
by barium enema examination and more than half of these carcinomas would not have 
been included in the planned resection. Because it provides the opportunity to remove 
synchronous polyps outside the planned area of resection, preoperative colonoscopy in 
patients with colorectal carcinoma is favored.
If colonoscopy is unavailable, flexible sigmoidoscopy and double contrast 
barium enema study should be performed. Most authors believe that air contrast 
enemas are more sensitive in detecting carcinoma of the colon however Johnson et al 
found no difference in either the rate of error or the ability to find lesions in an earlier 
stage when the results of barium enema study and a double – contrast barium enema 
study were compared.
ASSESSMENT OF CARCINOMA OF RECTUM:
Most patients with carcinoma in proximal or distal location can undergo 
sphincter saving procedure with resection of the lesion and restoration of bowel 
continuity for patients with carcinoma in a distal rectal location, therapeutic options 
are based on preoperative assessment of the lesion. Favorable localized lesions can be 
treated with either local excision or fulguration. Thus, abdomino – perineal resection 
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and a permanent stoma can be avoided by accurate evolution including the size of the 
lesion extent of circumferential involvement degree of differentiation and depth of 
invasion. Methods of preoperative assessment include the use of digital rectal 
examination proctoscopy and intra rectal ultra sonography and other imaging 
techniques.
DIGITAL RECTAL EXAMINATION
o Most important clinical examination
o 75% rectal cancers are palpable
o Exact length from anal verge, nature of lesion, extent ,circumference ,mobility 
and fixity to surrounding structures
o Growth in redundant sigmoid colon
o Pelvic deposits of proximal colon
ENDOSCOPIC ULTRASONOGRAPHY
o Endorectal USG
  -Best study in distal 12cm of rectum
 -High frequency probe 10MHz  is used
 -T staging very accurate
o T2- T3 differentiation is more accurate
o Nodal pickup rate is 59%
 PREVENTION OF SEPSIS:
Factors that have an important impact and reduce the changes of postoperative 
sepsis and leakage are
- Prophylactic antibiotics
- Mechanical bowel preparation
- Surgical technique like rapidity of operation exquisite and gentle 
handling of tissue. Techniques of suturing and anastomosis and 
complete homeostasis and avoidance of dead space.
CT
o Liver metastasis
o Site,size& location of the lesion
o Noncontrast  -Hypodense lesion
o Contrast - Hypodense or isodense
o Lymphnodes—sensitivity increases when size> 1cm
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MRI
o Indeterminate liver lesion on CT
o Rectal lesion
o Endorectal,pelvic coil - improve pick up rate
o Endorectal coil - accurate T staging
PREPARATION OF THE BOWEL:
Two techniques for accomplishing a surgery of “Near clean Category” a 
evolved with one there was mechanical cleaning of the bowel with other various 
antimicrobial agent were given to sterilize the gut.
PROPHYLACTIC ANTIBIOTICS:
Mechanical preparation does not remove from the colon all the bacteria. For 
this reason many surgeons used to give a non – absorbable antibiotic for a few days 
prior to operation. There is conclusive evidence that the use of prophylactic broad 
spectrum antibiotics effective against both aerobic and anaerobic organism can 
significantly reduce the risk of subsequent wound infection. The most commonly used 
combinations are metronidazole and aminoglycoside or cephalosporin. The drugs 
would be given with the premedication or at the anesthetic induction in order to 
achieve the maximum tissue concentration at the cefuroxime 750 mgs plus 
metranidazole 500mg 1 hour prior to surgery plus another two doses of each Drug at 6 
and 12 Hrs After surgery.
There is little doubt that good mechanical cleansing of the bowel is of 
considerable value. Traditionally this has been achieved by placing the patient on a 
liquid or elemental diet for 2-3 days followed by the administration of a cathartic 
agent. Nowadays a modified technique involves the use of polyethylene glycol (peglec 
solution)  which can be drunk or administered by a nasogastic tube 24 hours preceding 
the planned procedure. This can however lead to potassium loss which may be severe 
in the elderly patient who are already on diuretics and requires up to date electrolyte 
estimation prior to operation. Adequate mechanical preparation may not be possible in 
those patients with an obstructing lesion or those patients coming to emergency 
surgery. On table lavage of the colon proximal to the obstruction using the appendix 
stump as a portal entry can be very effective and permits primary anastomosis to be 
performed more safely.
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PRINCIPLES OF SURGICAL OPTION:
The goal of surgery is to maximize the change for cure through embolic 
removal of the entire locoregional tumour burden. Many factors influence the planning 
and conduct of the operation. The age and condition of the patient as well as the stage 
and extent of the tumour are important variables that help to define the surgical 
approach. Other factors such as the surgeon’s bias., level of experience and philosophy 
of training influence the course of treatment. The principles on which the surgeon can 
base an operative strategy are derived from the results of experimental studies and 
from the accumulated experience of several generations of surgeons.
ANATOMY
RECTUM
 Rectum starts at S 3 and follows the curve of       the sacrum
 It has 3 lateral curve   2 in the  left side 1 in  the right side
 It enters as anal canal at the level of levator ani-puborectalis
 Dilated part is called ampulla                                                      
An understanding of the vascular and lymphatic anatomy of the colon and 
rectum is crucial for establishing an effective operative strategy. The pathways for 
lymphatic drainage of the colon and rectum and the location of the lymph node basins 
define the extent of the mesenteric resection. A brief review of the relevant anatomy 
well help to lay a foundation for further discussion.
MESORECTUM
 Anatomically the word is a  misnomer
 It is a cushion of fatty tissue,that surrounds the rectum  posterolaterally and is 
covered by  a membrane called fascia propria
 Posteriorly it is thick and extends from promontory to waldeyers fascia 
.Anteriorly it is absent in   intraperitoneal portion of the rectum and it is thin in 
the extaperitoneal portion of the rectum
 Laterally it intermingles with lateral ligaments 
 It contains superior rectal vessels and lymphnodes
FASCIA  -RECTUM
Fascia propria
      Visceral layer of the endopelvicfascia covering the mesorectum
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Denonvilliers fascia
      Interposed between rectum and bladder
 Waldayers fascia
    Between rectum and sacrum contains S.R.A
Lateral ligament of the  rectum
     Between mesorectum and pelvic sidewall contains M.R.A and nervi eigentis
BLOOD SUPPLY-RECTUM
Superior rectal A  -I.M.A
Middle rectal  A    -Internal iliac A
Inferior rectal A    -Internal iliac A
VENOUS DRAINAGE
Rectum -S.R.V         Portal circulation
              -M.R.V      systemic circulation                                    
   -I  .R.V     systemic circulation 
ONCOLOGIAL APPLICATION
Venous drainage of S.M.V and I.M.V is to the portal vein .So liver metastasis 
is common
Venous drainage of the lower rectum is in both portal and caval system. Hence 
pulmonary metastases is more common in rectal cancer than colon cancer
LYMPHATIC DRAINAGE
First tier  -Epicolic nodes 
        adjacent to colon
Second tier – Para colic                                    
        along the marginal vessels
Third tier – intermediate nodes 
        along the named branch
Fourth tier – Principle node 
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         along the S.M.A,  I.M.A
o The majority of  the L.D of the rectum passes upwards along the S.R.A 
towards I.M.A
o The part of the rectum , 4-8 cm from anal verge    drains laterally along 
M.R.A to the iliac nodes  
ONCOLOGICAL APPLICATION
In colo-rectal  cancer ,chance of cure is high after radical surgery when nodal 
disease is limited to intermediate nodes.  
But if principle nodes are involved it is incurable
NERVE SUPPLY-RECTUM
Sympathetic –  Hypogastric nerve
    Hypo gastric plexus
       - at sacral promontary 
   Pelvic plexus 
       – At lateral wall of the rectum
   Para sympathetic –Nervi ergentis
     Pelvic plexus
ONCOLOGICAL APPLICATION
Radical treatment of rectal cancer results in high rate  of impotence in male 
In female it is unknown
 – Lack of definition of impotence in female
Pelvic autonomic nerve should be preserved by careful sharp dissection
Anorectal sensation is lost after low ant.resection and coloanal anastomosis 
.But regained within a year
Cancer invasion in pubo-rectalis and sphincters result in incontinence
MICRO STRUCTURE
No villi
1.Mucosa     -Surface epithelium
                    - lamina propria
                    - muscularis mucosa
2.Sub mucosa 
3.Muscular
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4.Sub serosa
5.Serosa 
Tis    Carcinoma insitu 
        Intraepithelial or invasion of lamina propria
 In other parts of the G.I.T , carcinoma insitu- cancer cells  limited to 
intraepithelial  Iayer
 SURGEON RELATED PROGNOSTIC FACTORS
These are factors of possible prognostic significance that are directly related to 
the conduct of the operation. These included the extent of the margins of resection, 
both intraluminally and extraluminally the extent of lymphatic resection the timing 
and level of vascular ligation the intraluminal use of cytotoxic solutions and the 
anastomatic technique. The consequences of preoperative blood transfusions or intra 
operative spillage may also adversely affect treatment outcome.
1. INTRALUMINAL RECURRENCE:
Suture line recurrence is often referred to as the tip of the iceberg because it is 
frequently associated with a much large extraluminal recurrence. In this situation the 
intraluminal recurrence is the result of invasion by the extracolonic tumour. There are 
cases however recurrence is isolated to the site of the anastomosis. The exact 
incidence of such recurrence is unknown although figures in the literature range from 
5% to 18% of patients.
Some clinicians have observed the anastomotic recurrence is more common in 
colocolic or colorectal anastomoses than in ilecoloic anastomoses. An inadequate 
distal margin of resection is one of many possible explanations for this clinical 
observation. The potential for contiguous microscopic intramural spread of colorectal 
carcinoma has been a source of controversy for the greater part of this century. 
“Retrospective studies by Lofgren and associates and Copeland et al showed 
diminished survival rates fro patients whose margins of resection beyond the gross 
extent of the tumour were less than 5.5cm and 5.0cm respectively. Histopahtologic 
studies have failed to identify longitudinal intramural spread of tumour for distance 
greater than 12mm however prompting clinicians stresses the requisite length of distal 
margin clearance. Most surgeons currently accept 2 cm beyond the distal edge of the 
tumour as the minimum length forth resection margin. Selecting the length of the 
distal margin can be the margin may determine whether sphincter – saving resection is 
an option. Achieving wide resection margins for intra peritoneal rectal tumour is 
usually not problematic. The extent of resection is determined by the blood supply to 
the involved segment. It seems likely that pathophysiologic mechanisms other than 
residual intramural microscopic disease are responsible for intra luminal recurrence 
after curative resection for carcinoma of the colon and rectum. Additional hypotheses 
to explain the pathogenesis include the implantation of exfoliated cancer cells at the 
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anastomosis and metachronous carcinogenesis at a site of greater epithelial 
vulnerability.
The assumption that exfoliated cancer cells can implant on mucosal surfaces 
and produce local recurrence dates to the early part of this century. Reports of tumour 
recurrence at unusual sites such as hemorrhoidectomy wounds and anal fistulas 
provided clinical support for the cell implantation hypothesis. Indirect support was 
derived from a number of studies reporting a reduced incidence of anastomotic 
recurrence after the use of measures to destroy exfoliated cells. Experimental data 
exist both to support and to refute the cell implantation hypothesis of anastomotic 
recurrence. Therefore the viability and implantation potential of the exfoliated cancer 
cell remains a debatable point.
Whether anastomotic technique influence the risk for suture line recurrence 
remains a controversial question. It has been suggested that exfoliated cancer cells 
would be implanted in the anastomosis by the suture material. Acceptance of this view 
led to widespread use of operative measures designed to destroy exfoliated cancer 
cells. These measures included irrigation of the colon with cytotoxic solutions such as 
mercuric per chloride or sodium hypochlorite and occlusion of the lumen proximal 
and distal to the tumour prior to mobilization of the colon. Studies in animal models 
suggested that the use of iodized cat gut suture material revented implantation of 
exfoliated tumour cells at the anastomosis. More recent studies have suggested that 
monofilament suture material is less prone to collect and implant malignant cells than 
is braided suture material. Malignant cells have also been found to collect on 
anastamotic staples. Retrospective studies investigating tumour recurrence have 
yielded conflicting results. Askyol et al reported a decrease in the tumour recurrence 
and cancer specific mortality rates in patients receiving a stapled anastomosis.
Colorectal cancer cells are vulnerable to commonly used irrigation solution 
such as povidone – iodine or chlorhexidine – centrimide. It is reasonable to continue to 
advocate intraluminal irrigation with povidone – iodine until the results of a 
randomized study comparing this technique with placebo washout refute its 
justification. An additional explanation for the development of local recurrence is the 
metachronous carcinogenesis hypothesis. Biologic changes in the mucosa at the site of 
colo rectal anastomosis may increase its susceptibility to carcinogenesis.
Inadvertent perforation of the colon during resection for carcinoma has been 
associated with a higher incidence of local recurrence. It has been proposed the 
recurrence results from implantation of viable tumour cells spilled at the time of 
perforation. However it is unclear whether the poorer outcome associated with intra 
operative perforation of the colon reflects the consequences of tumour spillage or is 
simply a marker for a  more locally advanced tumour. Inadvertent perforations tends 
to occur more commonly during mobilization of carcinomas of the rectum. The risk of 
perforation is increased when the cancer is adherent to adjacent structure. Meticulous 
dissection is required to minimize the risk for this intra operative mishap. Slanez44 
reviewed the treatment outcome in 174 patients whose operation of colorectal 
carcinoma was complicated by preforation of the colon or rectum. Local recurrence of 
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the carcinoma was documented in 65% of these patients and for patients with Dukes 
stage C carcinomas the rate of local recurrence was 87%. Only 29% of patients in this 
series survived 5 years. When the site of perforation was adjacent to the carcinoma the 
5 year survival rates for patients with carcinomas of the colon and rectum were 14% 
and 9.3% respectively.
Ziengibl reported intra operative perforation of the rectum in 8.7% of 1360 
patients undergoing resection of rectal carcinoma, local recurrence developed in 39% 
of these patients compared with 12.9% in patients whose tumour was resected without 
perforation. The 5 year survival rate decreased form 70% to 44% with intra operative 
perforation of the rectum.
Inadvertent perforation of the colon or rectum during operation for colorectal 
carcinoma is an adverse prognostic indicator and should be noted in the operative 
record.
2. NO TOUCH TECHNIQUE:
Studies performed in the 1950’s identified tumour cells in the mesenteric 
venous blood of patients with carcinoma of the colon and rectum. This finding 
suggested that manipulation of the tumour would increase the probability of various 
embolization of tumour cells. The no- touch isolation technique was designed to 
reduce the likelihood of venous metastases. Turnbull, Kyle.K and associates described 
a technique in which lymph vascular isolation and ligation was performed prior to 
mobilization and manipulation of the tumour – bearing segment of the colon. In 
resection of carcinomas involving the left colon and rectum the lymph vascular 
pedicels are exposed in the retro peritoneum and divided prior to mobilization of the 
colon.
The uncorrected 5-year survival rates were 51% utilizing the no-touch 
technique and 35% utilizing the conventional technique. The difference in crude 5-
year survival rates was greates (58% versus 28%) for patients with dukes stage C 
lesions. The authors believed that the no-touch technique was responsible for the 
better survival rate.
The study by Turnbull and associates has been criticized because it was 
nonrandomized retrospective study that relied on historical controls subjects. (Wiggers 
et al) performed a multi center randomized trial comparing the no-touch isolation 
technique with conventional resection of the colon in 236 patients.
The absolute 5 year survival rates with the no-touch and conventional 
technique were 59.8% and 56.3% respectively a difference that was not statistically 
significant. However liver metastases occurred later and less frequently in the patients 
with advanced carcinomas of the sigmoid colon or with carcinomas demonstrating 
vascular invasion. The technique was easily performed in the patients and Juan J 
Nogueras recommended the no-touch isolation technique for resection of colorectal 
carcinomas because his analysis suggested a tendency for a better treatment outcome.
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Others have criticized the no-touch technique because of the potential for 
injury to adjacent structures during ligation of the lymphovascular pedicle. Because 
this maneuver is performed prior to full mobilization of the colon, exposure of the 
vascular pedicle may cause injury to  the ureter, duodenum and large vessels. Miles 
EE described the technique of adbominoperineal resection for treating rectal 
carcinomas and advocated  ligation of the rectosigmoid mesentry at the level of the 
left colic artery.
Anatomic studies provide data to support a policy of extended mesenteric 
resection. (Gabriel WB et al) 50 performed detailed studies on the pattern of lymphatic 
spread in rectal cancer. Skip metastases whereby distant nodes are positive while local 
nodes are negative occurred in fewer than 5% of patients, and the investigators 
concluded that lymphatic metastases progressed in an orderly fashion along the lymph 
node chain. In a related study Grinnel Rs described retrograde lymphatic metastases in 
patients whose proximal lymphatic channels were occluded by tumour dissemination 
in a retrograde direction along accessory lymphatic metastases in 4.3% of the patients 
studied.
Goligher JC demonstrated that the distance between the origin of the IMA and 
the take off of the left colic artery measured an average of 4 cm. From this segment of 
mesentery as many as 10 lymph nodes can be retrieved. Authors advocating high 
ligation of the IMA for treatment of carcinomas of the left colon and rectum have 
documented a 14% to 22% incidence of lymph node metastases in the segment of 
mesentery between the origin of the artery and the take off of the left colic artery. It is 
presumed that extended mesenteric resection to encompass these lymph nodes would 
increase he disease – free survival rate.
Grinnell concluded that involvement of the apical lymph nodes with metastatic 
disease is a marker for distant spread. No survival benefit could be demonstrated from 
high ligation of the IMA.
3. ADJACENT ORGAN INVOLEMENT:
In approximately 10% patients with colorectal cancer the tumour mass is 
adherent to adjacent structures. Any organ or structure that neighbours the tumours 
can be involved. Fixation of the tumour mass to an organ does not always imply direct 
tumour invasion. Although the majority of cases involve malignant invasion the 
attachment represents an inflammatory adhesion in as many as 43% of cases. 
Preoperative testing may not demonstrate the presence of adjacent organ involvement 
and it is impossible to determine accurately the histologic nature of the attachment 
between the rectum and the involved organ at the time of operation Biopsy of the 
interposing tissue is not recommended because of concerns about the likelihood of 
sampling error and the potential for tumour spillage. Lysis of adhesions with 
separation of the adjacent organ form the colon and rectum increases the risk of local 
tumour recurrence and should not be performed. En bloc resection of the tumour mass 
to encompass adjacent organ involvement is the procedure of choice. Hunter examined 
the results of treatment in 43 patients with colorectal cancer involving adjacent organs. 
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Separation of the tumour from adjacent organs prior to colon resection was associated 
with local recurrence of cancer in 77% of patients compared with 36% after en bloc 
resection of the colon and adjacent organ. Similarly the crude 5-year survival rates 
were 24% and 61% after organ separation and en bloc resection respectively. En bloc 
resection was performed with minimal morbidity and no deaths. The organs included 
the small intestine, bladder, uterus, vagina, peritoneum, ovary, follapian tubes and 
duodenum.
Carcinomas of the left colon tend to involve the bladder more frequently and 
en bloc resection with partial cystectomy is possible in most cases. Management of 
carcinoma of the colon that involves and adjacent ureter is another challenging 
problem. In this situation segmental resection of the involved ureter with 
ureteroneocystostomy offers the set option. There are situations however in which 
involvement of vital structures such as the inferior vena cava, aorta, or iliac vessels 
precludes en bloc resection of a colon carcinoma.
4. OOPHORECTOMY:
The role of prophylactic oophorectomy at the colonic resection for cancer has 
been debated sine the technique was initially proposed by (Burt CAV) in 1951. The 
patients with ovarian recurrence were significantly younger and had a poor prognosis, 
with a mean survival of 17months from the time of operation. Because of the low 
incidence of metachronous ovarian metastases, Juan J Nogueras did not support 
prophylactic oophorectomy but recommended when there is direct involvement with 
tumour or obvious abnormality or when patients request oophorectomy. Once ovarian 
metastases develop the prognosis is poor.
5. PRE OPERATIVE BLOOD TRANSFUSION:
There have been several reports implicating preoperative blood transfusion in 
lower survival rates after surgery for colorectal cancer reports suggest that in some 
unrefined manner transfusion alters the host immune response creating a permissive 
environment for tumour growth. Initial interest in this relation was based in part on the 
work of Opelz et al 58 who reported that renal allograft survival was altered 
significantly if the patients had received a pre-transplant blood transfusion this 
observation encouraged investigation of the immunologic effects of blood transfusion.
Blood transfusions increase the number of suppressor – T lymphocytes and 
stimulate the production of a variety of antibodies. The activity of natural killer cells is 
depressed in the transfused patient. Transfusion also promotes the release of 
prostaglandin E2 from monocytes which inhibits interleukin –2 production further 
suppressing the immune response thus blood transfusions have a direct effect on 
specific functions that directly affect host defense mechanisms.
The observation that factors in the immune system can influence tumour 
growth provides circumstantial evidence for an association between preoperative 
blood transfusion and poor treatment outcome for patients with colorectal carcinoma. 
Nature killer cells and cytotoxic lymphocytes are capable of destroying tumour cells. 
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Because transfusions can alter the function of these immunologically active cells a 
relation between blood transfusion and the prognosis of patients with colon and rectal 
cancer has been sought for the last decade. Blood transfusion should be administered 
only when there is a specific medical necessity.
A REVIEW OF SURGICAL OPTION
In the first quarter of this century a review of surgical option for the treatment 
of rectal cancer would have presented abdomino – perineal resection with permanent 
colostomy as initiated by Miles and might cautiously if at all have referred to any 
sphincter saving procedure. Today the options are numerous that continuity restoration 
or preservation probably are achieved more commonly than is permanent colostomy 
chosen. Tough adjunctive scientific advances have helped effect this transition. The 
contribution of surgeon form many nations may have influenced by the creative and 
innovative concept of selective treatment of cancers championed by (George Crile Jr.) 
The principal option for treatment of rectal cancer are
1. Local Treatment
2. Adbomino – perineal resection with colostomy
3. Extended Hartman resection with colostomy
4. Anterior resection withcolorectal anastomosis such as  conventional stutured 
anastomosis and stapled anastomosis.
5. Abdomino – perineal approach with anastomosis such as pull through 
procedure and per anal anastomosis.
6. Pelvic Evisceration (Burschwig operation)
7. Minimal access surgery (Laparoscopic)
SURGICAL  MANAGEMENT
• Extent of  disease
• comorbidities
CLASSIFICATION 
• Curative
• Noncurative
MANAGEMENT OF POTENTIALLY CURABLE RECTAL CANCER
• Pretreatment evaluation
• Preoperative preparation
• Operative procedure
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• Postoperative management
• Follow up
PRETREATMENT EVALUATION
• Extent of disease 
• Condition of rest of the bowel
• comorbidities
PREOPERATIVE PREPARATION
• Bowel preparation
• Antibiotics
• DVT prophylaxis
• Stoma advice
PRINCIPLES OF MODERN SURGERY
• Radical surgery when cure is possible
• Palliative procedure when cure cannot be obtained
RADICAL RESECTION
• Adequate margin of normal colon
• Associated vascular pedicle with as much of the corresponding lymph bearing 
structures as possible
EXTENT OF RESECTION
• Determined by the blood vessels that must be divided to remove the lymphatic 
drainage of the tumor bearing portion of the colon with tumor free margins
• At least 5cm. of normal bowel proximal and distal to the tumor
• Resection of intermediate and principal nodes 
SURGICAL PROCEDURES FOR RECTAL CANCER
• Abdominoperineal resection
• Multivisceral resections
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• Low anterior resection
• Proctectomy and coloanal anastomosis
PRINCIPLES OF THE SURGICAL MANAGEMENT OF RECTAL 
CANCER
• Removal of the primary tumor with adequate margins of normal tissue
• Treatment of the draining lymphatics
• Restoration of function
APR
• Indicated for most tumors of the lower third rectum and selected bulky tumors 
of the middle third rectum
• Combined transabdominal and perineal procedure
• Involves complete resection of the rectum,mesorectum,levator muscles and 
anus with formation of a permanent colostomy
• Rectal cancer involving levator muscle or anal sphincter are best managed by 
by APR
TEM
• Should be performed in all cases done with curative potential
• Basis: high incidence of nodal involvement in rectal cancers
• Reduces the local recurrence rate
SPHINCTER SAVING PROCEDURES
o Low Anterior Resection- Colorectal Anastomosis.
o Extended Low Anterior Resection- Coloanal Anastomosis.
o Local Excision.
o Ablative therapies.
OPTIONS ACCORDING TO THE SITE:
o Upper Rectum –
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Anterior Resection- Colorectal Anastomosis.
o Middle Rectum –
 Low Anterior Resection- Colorectal Anastomosis.
o Lower Rectum – 
Extended Low Anterior Resection- Coloanal Anastomosis.
LOCAL EXCISION
o Highly selected patients (only 10% suitable)
o Patients refusing surgery/colostomy.
o Patients medically unfit for Major surgery.
o Local palliation.
BASIS OF LOCAL EXCISION
o To decrease chances of Local recurrence.
o To exclude patients with N +ve disease.
LOCATION OF THE TUMOR
o 6-8 cm from anal verge – Transanal Approach.
o Middle 1/3 rectum – Transanal Endoscopic      Microsurgery  or  Posterior 
Approach.
  Upper 1/3 rectum
Full thickness excision         Risk of Fecal  
       not possible                       spillage
SIZE
o Should be < 3 cm.
o Should not occupy > 1/3 of circumference.
GRADE
Only Well (or ) Moderately differentiated tumors
PREOPERATVE EVALUATION
o Clinical examination is most crucial.
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o Endorectal USG  is a MUST
   To assess T stage         To exclude N +ve
         Accurately                        disease
o MRI with Endorectal coil.
APPROACH
o TRANSANAL
– Transanal Excision.
– Transanal Endoscopic Microsurgery.
o POSTERIOR APPROACH
– Trans-Sacral – Kraske’s
– Trans-Sphincteric – York Mason’s
TRANSANAL APPROACH
o Commonly used.
o Suitable for Lower third lesions.
o Good lighting and retraction essential.
TRANSANAL ENDOSCOPIC MICROSURGERY
o Carbondioxide insufflation via 40 mm operating Rectoscope.
o X 6 magnification.
o Specialized Endoscopic instruments.
TRANS-SACRAL – KRASKE’S
o For Middle third rectal lesions.
o Coccyx and Lower two segments of Sacrum excised.
o Increased risk of fecal fistula.
TRANS-SPHINCTERIC – YORK MASON’S
o No Sacrectomy.
o Sphincteric complex carefully delineated,divided and reapproximated.
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o Decreased risk of fecal fistula.
o Increased  risk of incontinence.
ELECTROCOAGULATION / LASER
o Patients refusing surgery/colostomy.
o Patients medically unfit for Major surgery.
o Same selection criteria.
o Great care in Anterior lesions.
o Disadvt:Absence of pathology,multiple sessions.
ENDOCAVITARY RT – PAPILLION'S
o Direct contact irradiation with Cone.
o Tumor doses of 10,000-12,000 cGy reached.
o 3 – 4 sittings over 8 wks with 2 wk intervals.
o Mucosal necrosis.
o Can be combined with EBRT for T2 lesions.
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RADIATION THERAPY
The main reasons for favoring pre operative radiation have been the desire to 
reduce their rate of both pelvic recurrence and extra pelvic metastases based on the 
assumption that some metastases arise from cells released during inter operative 
manipulation of the cancer, the lower likelihood of late radiation enteritis because 
small bowel is less likely to be adherent in the pelvis prior surgery, and the relatively 
greater radio responsiveness of normally oxygenated cancer cells relative to cells and 
tissues that may be hypoxic secondary to alteration in vascularity resulting from pelvic 
surgery. None of the randomized trials has demonstrated a reproducible and 
statistically significant increase in the 5 year survival rates of patients those to have 
undergone curative surgery after radiation. Short-course relatively intense 
fractionation schemes such as the 25 Gy in firve fractions in 1 week by Swedish 
investigators did result in a significant improvement in cancer specific survival 
(approximately 65% Vs 68% at 5 years, p = 0.05) but not in overall survival.
With radiation schedules equivalent to 34.5 Gy in 3 weeks or more there have 
been some delays in would heating although these were not considered clinically 
significant. The risk of leakage from colorectal anastomoses was not increased by 
doses of 34.5Gy in 3 weeks or 25 Gy in 1 week the randomized train and in non 
randomized studies, doses of 45 Gy in 5 weeks similarly not adversely affected 
anastomotic healing. Post operative radiation therapy has been favoured by those who 
wish to select patients for adjuvant treatment by histopathology prognostic features 
that have not bee down staged buy radiation. The patients usually selected for post 
operative adjuvant radiation therapy are those in whom there tumour is found to have 
extended into perirectual tissues (Duke’s stage B AJC stage T3 NO or TANO0 or into 
regional lymph nodes (Duke’s stage C: AJC stage N1-3) Neither survival nor 
extrapelic tumour recurrence rates have been significantly improved by doses as high 
as 50 Gy in 5 weeks. Although the risk of pelvic recurrence has been reduced in 
several studies there has still been a disappointingly high risk of such recurrences n the 
range of 15% to 25% Treatment related morbidity as measured by the risk of late 
small-bowel obstruction was increased in some studies although there was no 
significant preoperative and postoperative radiation (sandwich) therapy have been 
designed to exploit the theoritical benefits of low dose preoperative irradiation and to 
select patients for additional adjuvant therapy on the basis of the histopathologic 
extent of the cancer (Basle V et al)
RADIATION AND CHEMOTHERAPHY:
Combinations of radiation and chemotherapy are being studied because of the 
recognition that improvement in survival rates will require reduction of the rates of 
recurrence both at the primary tumour site and outside the pelvis and because so
 for radiation of chemotherapy have each been shown to produce relatively limited 
benefits when used alone.
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The European Organisation for Research on Treatment of Cancer (EORTC) 
conducted a trial in which preoperative irradiation was combined with concurrent 5-
flurouracil (5FU) 78. A regimen of 34.5Gy in 3 weeks combined with bolus injections 
of 5-FU 10mg/kg body weight on each of the first 4 days of irradiation was compared 
with radiation therapy alone. No chemotherapy was given postoperatively and there 
was no surgical control arm. Although the overall survival rates favored the radiation 
only adjuvant (59% versus 46% at 5 years; p = 0.06) the mortality rates from cancer 
were similar as were the pelvic recurrence rates. Trials conducted by the Gastor 
intestinal Tumour Study Group (GITSG) 79,80 and the North Central Cancer 
Treatment Group (NCCTG) and Easter co-operative Oncology Group (ECOG) 
included radiation 5-FU and MeCCU (semustine). But they failed to demonstrate any 
advantage of the combination over one of other of the adjuvant modalities alone.
Although the combination of 5-FU and semustine has been associated with 
improvements in the survival rate in three trials there has been considerable reluctance 
to use semustine because of its toxicity. Particularly its potential for inducing blood 
dyscrasias. Recent randomized trials in which patients received postoperative 
irradiation and 5-FU either with or without semustine have not shown any significant 
differences in failure pattern or survival rates. This result has been interpreted to mean 
that semustine does not add to the benefits of 5-FU and irradiation and that semustine 
can be excluded from adjuvant protocols.
The combinations of irradiation and chemotherapy used n the trials described 
above have been fairly well tolerated, and the risk of serious late morbidity such as 
enteritis and of treatment related death were generally similar to those of patients 
treated with radiation alone.
RECURRENT CANCER:
Radiations is frequently used to treat postoperative recurrence in the area of the 
primary tumour and again, there has been more experience with the management of 
rectal cancers. Local recurrences from either rectal or colon cancers seldom are 
completely resectable even when surgery is combined with irradiation. The symptoms 
of pain and bleeding respond to radiation more frequently than do mucous discharge 
or nerve entrapment. Improvement in symptoms is generally reported in 50% to 90% 
of patients with a measurable reduction in the size of tumour masses in 25% to 60%. 
However it has been observed that although some degree of symptomatic relief is 
usual such relief is often relatively short lived even after moderately high radiation 
doses. The combination of cytotoxic chemotherapy and radiation for patients with 
recurrent or unresectable cancer is of uncertain value although widely used.
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CHEMOTHERAPY
5 Flurouracil was first reported to be effective for colorectal cancer in 1950s. 
When the drug is administered by intravenous bolus, the response rate is 
approximately 20%. The side effects of 5-FU are usually well tolerated and may 
include fatigue mild nausea diarrhoea, mucositis or myelosuppression patients who 
respond to treatment may experience improvement in tumour related constitutional 
symptoms such as fatigue and anorexia.
Efforts have been made to enhace the activity of 5-FU by co-administration 
with other agents. Although methotrexate has little antitumour activity when used as a 
single agent for colorectal cancer, the sequential administration of methotrexate 
followed by 5-FU has been reported to the more effective than 5-FU alone. Response 
rates greater than 40% have been achieved. Similarly the potency can be enhanced by 
the administration of recuded folated (leucovorin). When 5-FU is given in 
combination with leucovorin response rates range from 21% to 48%. A randomized 
prospective trail compared 5-FU alone, sequential methotrexate plus 5-FU and 
leucovorin plus 5-FU among patients with previously untreated metastatic colorectal 
cancer. Response rates of 11%, 5% and 49.8% respectively were achieved. The side 
effects associated with the regimen of 5-FU plus leucovorin are similar to those of 5-
FU alone although the severity may be greater. Patients may develop severe diarrhoea 
or mucositis often necessitating delays in treatment and dose modification. 
Hospitalization for intravenous hydration occasionally is necessary. The combination 
of 5-FU with alpha – interferon appears to be considerable more effective than 5-FU 
with alpha  interferon appears to be considerable more effective than 5-FU alone. 
Alpha interferon is one member of a family of cytokines that exhibit cytotoxic and 
immunostimulatory effects.
Walder Sa et al treated 17 patients with advanced colorectal cancer using 
recombinant alpha-interferon administered subcutaneously three times per week and a 
continuous infusion of 5-FU for 5 days followed by weekly intravenous doses. A 76% 
response rate was reported. 5- Fluorouracil has been used in combination with methyl-
CCNU (Semustine) vincristine (MOF), MOF plus streptozocin, cisplatin containing 
regimens, and other have been used. Widely variable response rates have been 
reported. Some of which have appeared to be slightly superior to those of single agent 
therapy. However toxicity is greatly increased with combination therapy and there is 
no evidence of improved survival.
NEWER CHEMOTHERAPY 
FOLFIRI REGIMEN 
Irinotecan 
5FU
Leucovorin 
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FOLFOX REGIMEN
Oxaliplatin (Used in Metastatic disease)
5FU
Leucovorin
5FU acts as a radio sensitiser when used concurrently with Radiotherapy.   
ADJUVANT CHEMOTHERAPY AND IMMUNITHERAPY:
National intergroup (USA) undertook prospective randomized study which has 
recently reported a survival benefit when 5FU and levamisole are combined. As 
adjuvant therapy for colonic cancer. There has been 33% reduction in deaths for 
Duke’s C Patients. On the combination of this regime. This difference was not realized 
for patients with duke’s B lesions but the recurrence rate has been smaller. Levamisole 
has a wide spectrum of activity from the modulation or of many cellular enzyme 
systems to the protestation of human interferon and 1L-2. It appears to potentiate the 
action 5-FU in a way that demands urgent resolution.
MANAGEMENT OF RECURRENT AND METASTATIC
CARCINOMA
Surveillance should be most intensive early because recurrent disease develops 
within the first 2 years after primary resection in about 80% of patients.
LOCAL RECURRENCE:
Recurrent carcinoma may present as a localized tumour at the anastomosis or 
more commonly as recurrent disease in the bed of the primary carcinoma growing into 
the anastomotic area. The disease may be extensive and may involve regional lymph 
nodes.
Surgery is the only hope for cure these patients but frequently the extent and 
dissemination of the disease make complete excision impossible. In symptomatic 
patients, however maximal palliation can be accomplished by alternative surgical 
treatments such as resection, faecal diversion or a bypass procedure. Local palliation 
may be accomplished by alternative surgical treatments such as resection faecal 
diversion, or a by pass produced. Local palliation may be accomplished by transanal 
laser surgery or fulguration in patients with disseminated disease or in poor medical 
condition. More extensive operations including sacral resection or pelvic exenteration 
are reserved for patients with isolated recurrent disease who are in excellent medical 
condition. 
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LIVER METASTATES:
Colorectal carcinoma will metastasize to the liver in about 35% of patients. 
Half of these patients (10% to 20% of all patients) will have liver metastases at the 
time of primary resection  of the colon.
At present hepatic resection is the only curative treatment available for these 
patients. The median survival from the time of diagnosis of metastatic liver disease is 
about 4 to 12 months for unselected groups whereas 45% of patients with a solitary 
metastatic lesion may be alive at 2 years and 12% may be alive at 3 years. In the 
absence of resection however survival longer than 5 years is almost never possible.
The Grade of the tumour may have some influence on the survival of patients 
with untreated liver metastases. In the series by (Goslin et al) the median survival time 
for patients with well, moderately well and poorly differentiated tumour was 30,16 
and 6 months respectively. However the relation between the histologic findings and 
the extent of involvement of the liver was not reported.
BLOOD TRANSFUSION:
Blood transfusion has been alleged to affect survival after resection of primary 
colorectal carcinoma  similarly perioperative blood transfusion has been found to be 
an independent prognostic factor adversely affecting survival after resection of liver 
metastases. Specifically, for each additional unit of blood and death increased by 5% 
and 7% respectively. Further studies be directed toward decreasing blood loss during 
hepatic resection to minimize the need for blood transfusions.
Resection of synchronous liver metastases and colorectal carcinoma. Magnetic 
resonance imaging is more sensitive than CT and better defines the relation of the 
metastasis disease to the hepatic veins but is less effective for evaluation of extra 
hepatic disease.
At laparotomy for resection of colorectal carcinoma 10% to 26% of patients 
will have synchronous liver metastases. In usually, simultaneous liver resection has 
been performed with good results however and is safe when patients are probably liver 
as a solitary metastastic lesion that can be removed by limited resection minimal blood 
loss or contamination in an uncomplicated status that would permit both procedures 
and a surgeon who is comfortable in proceeding with the resection. No survival 
advantages exists performing simultaneous versus delayed resection of the liver.
UNRESECTABLE METASTASES:
Liver transplantation for patients with unresectable hepatic disease has been 
reported in Europe. Because of the shortage of donor organs and the lack of long term 
follow-up studies transplantation is not likely to be a feasible alternative for the 
treatment of patients with metastatic disease.
Alternative methods of treatment including the use of monoclonal antibodies 
and hepatic cryosurgery are under investigation any may prove to be of considerable 
benefit in the future.
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PULMONARY METASTASES:
It is estimated that pulmonary metastases will develop in about 10% of patients 
with colorectal carcinoma at some time in the course of the disease.  By that time in 
most patients disease will already have spread to other organs. Only 10% of these 
patients will actually have a solitary pulmonary metastatic lesion.
The only hope of cure for patients with pulmonary metastases from colorectal 
carcinoma is resection. In a collective review by Brister et al, the survival rate of 335 
patients in 12 series who underwent resection of pulmonary metastases form colorectal 
carcinoma was 70% at 2 years and 30% at 5 years. Clearly resection should be 
undertaken whenever a recurrent lesion limited to the lung is technically resectable. 
BRAIN METASTASES:
Carcinoma metastatic to the brain from a colorectal primary site is uncommon 
and is usually associated with disease elsewhere particularly in the lung. Metastatic 
carinoma of thebrain is usually diagnosed because of the presence of neurologic 
symptoms rather than during screeing.For months, an provides the best palliation 
without increased morality. At the same time. In the rare situation of a patient whose 
metastatic lesion in the brain is the only site of recurrence craniotomy may prolong 
survival.
OSSEOUS METASTASES:
The incidence of bone metastases among patients with disseminated colorectal 
carcinoma varies among different series. Osseous metastases which are uncommon 
may be the source of considerable pain. The diagnosis is usually achieved with bone 
scans. Palliative treatment by means of radiation is usually effective.
OVERIAN METASTASES:
The ovary is the site of metastatic diseases in 3% to 8% of women with 
colorectal carcinoma. Metachronous ovarian metastases cause considerable morbidity 
and overall are associated with poor survival. Patients with ovarian metastases of 
colorectal origin should undergo aggressive surgical therapy. Bilateral oophorectomy 
should be performed even in patients with unilateral ovarian involvement. Some 
authors recommended prophylactic bilateral oopherectomy as part of the initial 
surgical treatment for colorectal carcinoma in a premenopausal women with advanced 
stages of disease and in all postmenopausal women.
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MASS SCREENING STRATEGY
Current recommendations of the American Gastoroenterologic Association 
include digital rectal examinations and fecal occult blood tests annually beginning at 
the age 40 and flexible sigmoidoscopy at age 50 for the individual with average risk. 
A negative endoscopy in 2 consecutive years is followed by endoscopy every 3 years 
thereafter. High risk individuals with single positive fecal occult blood test requires 
evaluation by colonoscopy or flexible sigmoidoscopy couples with double contrast 
barium enema.
RESULTS
I. NUMBER AND SEX
Total Number of cases studied -50
Total Number of Male Patients -31
Total number of Female Patients -19
II. AGE
AGE DISTRIBUTION OF PATIENTS WITH CANCER RECTUM
Age in years No.of Patients Percentage
Male Female
11-20 1 2 6%
21-30 2 3 10%
31-40 3 3 12%
41-50 6 5 22%
51-60 13 4 34%
61-70 4 0 8%
Above 71 2 2 8%
As can be seen from the above table there is a predominance of Cancer rectum 
patients in the 5th and 6th decades of life. More than 50% of the studied belonged to 
this age group.
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III. CLINICAL PRESENTATION:
Sl.No. Complaints Number of Patients Percentage
1 Bleeding per rectum 36 72%
2 Constipation 24 48%
3 Pain 20 40%
4 Tenesmus 22 44%
5 Diarrhoea 8 16%
6 Obstruction 4 8%
7 Mass descending P/R 1 2%
As can be inferred from the above table the patients with carcinoma rectum 
presented to us predominantly with complaints of bleeding per rectum, constipation 
and pain.
IV. MACROSCOPIC APPEARANCE:
Macroscopic Appearance of  the lesion in patients with carcinoma rectum
Sl. No. Type of Lesion Number of Patients Percentage
1 Fungating (Ulcero proliferative) 24 48%
2 Ulcerative 16 32%
3 Annular 5 10%
4 Diffuse Infiltrating (Tubular) 5 10%
As it can be seen in the above table patients had predominately an 
ulceroproliferative or ulcerative type of lesions which constituted about 80% of the 
patients.
V. SITE
The distance of the lower extent of the lesion from the anal verge
Sl.No Distance from the anal verge Number of Patients Percentage
1 Up to 7 cm 31 62%
2 7-12cm 17 34%
3 Above 12 cm 2 4%
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At is can be seen in the table more than 60% of the  patients had lesions in the 
lower rectum itself.
VI. HISTOPATHOLOGY
The distribution of the cases according to their histopathology
Sl.No Distance from the anal verge Number of Patients Percentage
1 Well differentiated adenocarcinoma 18 36%
2 Moderately differentiated 
adenocarcinoma
12 24%
3 Poorly differentiated adenocarcinoma 8 16%
4 Infiltrating type of adenocarcinoma 7 14%
5 Mucinous adenocarcinoma 4 8%
6 Malignant melanoma 1 2%
Adenocarcinoma formed the majority of cases constituting about 98% of the 
cases studies.
VII. SURGERY
TYPES OF SUGERY DONE
SL.No Surgery Number of patients Percentage
1 Abdomino perineal 
resection
32 64%
2 Anterior resection 1 2%
3 Colostomy only 17 34%
VIII. DUKES STAGING
Dukes Staging On Operated Speciments (33 Cases)
SL.No Dukes Stage Number of patients Percentage
1 Dukes A 3 9.1%
2 Dukes B 8 24.2
3 Dukes C 22 66.6%
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INOPERABILITY
Number Of Cases Inoperable In Our Series Was 17 Cases
1 Bladder Invasion 8
2 Prostate invasion 3
3 Frozen Pelvis 2
4 Sacral invasion 2
5 Liver Secondaries with 
Ascites
2
X. MORBIDITY
1. Perineal wound infection 8/33 24.2%
2. Perineal wound gaping  1/33 3%
3. Abdominal wall infection 3/50 6%
4. Retention of urine 3/50 6%
5. Impotence 4/50 8%
XI. MORTALITY:
Post operative mortality in out study was 4% (2 cases) One patient died due to 
pulmonary Embolism in III rd Postoperative day following Elective surgery (APR 
done) One patient died due to Multiorgan failure in IInd postoperative  ay  ollowing 
emergency surgery (Laparotomy and palliative colostomy done for advanced  rectum 
presented with intestinal obstruction)
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DISCUSSION
Carcinoma rectum is one of  the commonest colorectal malignancy in Govt. 
Rajaji Hospital, Madurai. There was preponderance of males over females among 
patients who presented to us with cancer rectum. Through the colorectal carcinoma is 
considered to be disease of the old age in our study peak incidence of cancer rectum 
was one decade earlier than that of western series.
AGE
Though Rankline reported an incidence of 3.8% for rectal carcinoma below 30 
years in our study the incidence was about 16%
Goligher had reported an incidence of cancer rectum to be about 59% in 
patients below 60 years. But in our study it was 84%. This shows short the expectancy 
among Indian population.
SEX RATIO
Gilliland had reported an incidence of 54% male and 46% female while Jatzko 
had reported 54.1% male and 45.9% female. In out study the incidence was 62% male 
and 38% female. Jerome S. Abrams and Vermont had reported the incidence of 
male:female as 1:3:1 while in our study the ration in1:6:1
SYMPTOMS
The reason for patients needing medical attention was predominantly bleeding 
per rectum and was present in about 72% patients in our series. Whereas Michael 
Adoif et al had reported that 56% of patients complained of bleeding per rectum. 25 of 
our patients constituting about 48% had constipation.
Where as in rectum Michal ADOLF series it was 29%. 8% of our patients presented 
with obstruction where as it was 8.5% in Michael Adoiff series.
SITE
62% of our patients had lesions at the lower 1/3 of rectum while for Goligher it 
was about 35.3% and for jarvinen it was 46%. Similarly in our study lesion at middle 
1/3 of rectum was 34% which correlates well with regards to Goligher series of 28.7% 
and Jarvinen series of 31%. The lesions at upper 1.3 of rectum the incidence in our 
series was about 4% for Goligher it was about 36% and for Jarvinen it was 23% 
respectively.
In our series the commonest site of lesion was lower 1/3 of the rectum.
PATHOLOGY
On Macroscopic appearance ulcerative ulceroproliferative (Fungative) type of 
lesion constituted about 72% or our patients whereas proliferative type is the 
commonest type in western series.
54
HISTOLOGY
About 98% of lesions were Adenocarcinoma among this 36% patients had well 
differentiated Adenocarcinoma. 4 of our patients constituting about 8% had mucinous 
adenocarcinoma is more common in younger age group and behave aggressively.
SURGERY
In our surgery 33 out of 50 patients underwent definite surgery constituting 
about 66% while Jatzkog reported 85.6%. Abdomino perineal resection was the 
commenest surgery done number of patients who underwent palliative colostomy has 
17 (ie) 34%.
Once of our patients presented to us chronic Diarrhoea with right side hydro 
uretro nephrosis due to mid ureteric obstruction. Rectal examinations showed growth 
5cm from Anal verge. APR with resection of infiltrated ureter and uretro 
neocystostomy was done. Post Op period Uneventful.
68 male a case of Rectosigmoid growth presented with liver secondaries with 
intestinal obstruction. Palliative colostomy alone has done. Patient died on the 11nd 
post op day due to Multiorgan failure.
49/Male with features of sciatica and intestinal obstruction. We did palliative 
colostomy alone was done. USG abdomen & CT Spine showed Liver secondries and 
secondary lesions in lumbo sacral spine.
The commonest cause of inoperability in our series was anterior fixity to 
bladder and other organs constituting about 70.58% of inoperable patients. We had 3 
cases of Liver Secondaries with Ascites and all of were inoperable due to local causes.
DUKES STAGING
Regarding Dukes staging on operated speciment we had 9.1% in Dukes “A” 
24.2% in Dukes “B” 6.6% in Dukes “C” For Dukes it was 15% in stage “A” 35% in 
stage “B” 50% in stage “C”.
MORBIDITY
Regarding morbidity 24.2 of our patients who underwent abdominoperineal 
resection had perineal wound infection, and were treated with appropriate antibiotics 
after culture and sensitivity.
3% of our patients who underwent abdominoperineal resection had perineal 
wound gaping and were treated with daily dressing. It took nearly 6-7 weeks for the 
wound to heal.
Out of 50 patients who under went either definite surgery (or) Palliative 
colostomy 3 had Abdominal wound infection and were treated with antibiotics 6% of 
patients developed Retention. 8% of patients developed Erectile dysfunction.
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FOLLOW UP
All Pts had received Adjuvant chemotherapy with 5 FU with levamisole. 
During follow-up period 2 patients had developed pelvic recurrence and 1 patient had 
developed liver secondaries. Follow up sigmoidoscopy was done for the patient for 
whom low anterior resection done. Findings found to be normal.
MORTALITY:
Postoperative mortality in our study was 4% (2 cases)
One patient died due to pulmonary embolism in the IIIrd Postoperative day following 
Elective Surgery (APR Done)
One Patient died due to multiorgan failure in the IInd Postoperative day following 
emergency surgery (Laprotomy done for advanced CA Rectum with Intestinal 
Obstruction).
In our series the mortality in the immediate Post operative period was 4% where as 
Golighre had reported 6.7%mortality.
56
CONCLUSION
Incidence of ca rectum Male : Female ration in our series 1.6:1
Commonest age group involved was 5th and 6th decade
Carcinoma of recutm was relatively common in the younger age group in our series 
i.e. abour 28% of cases were below 40 years.
Bleeding per rectum was the commonest presentation of carcinoma rectum in 72% of 
patients.
The next common clinical presentation was constipation, in 48% of our patients.
We had only 4 cases of carcinoma rectum presenting as intestinal obstruction i.e. 8%
Ulceroproliferative (fungating Growth) type is the commonest type of lesions.
Lower 1/3 of the rectum was the commonest site of lesions.
Well differentiated adenocarcinoma was the commonest histopathological type.
Abdomino – perineal resection was done in 64% of our patients.
Anterior resection was done in 2% of our patients.
Dukes stage C was the commonest stage.
Anterior fixity was the commonest cause of inoperability.
Perineal would infection was the commonest complication in the postoperative period.
Postoperative mortality was 4%.
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